Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area mapk rac'

Search results for: 'research area mapk rac'

Items 31-40 of 155

Page
per page
  1. BIX 02189
    A5801 BIX 02189
    Target: MEK|ERK
    Summary: Selective MEK5 inhibitor
      ≥22.05 mg/mL
  2. BIX 02188
    A5803 BIX 02188
    Target: MEK
    Summary: MEK5 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥10.3 mg/mL
  3. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     9 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL
  4. AS 602801
    A3189 AS 602801
    Summary: Jun Kinase Inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.45 mg/mL
  5. EHT 1864
    B5487 EHT 1864
    Summary: Rac family small GTPases inhibitor
      ≥29.05 mg/mL
  6. TAK-715
    A8688 TAK-715
    Summary: p38 MAPK inhibitor
      ≥40 mg/mL
  7. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  8. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  9. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  10. VX-702
    A8687 VX-702
    Summary: P38α MAPK inhibitor,highly selective and ATP-competitive
      insoluble in H2O; ≥20.2 mg/mL

Items 31-40 of 155

Page
per page